NVOS Stock: Novo Integrated Sciences Price & Analysis
If you’ve typed “NVOS stock” into a search bar, you’re probably trying to figure out one of two things: what Novo Integrated Sciences actually does, or why its share price has swung so wildly over the past few years. This guide covers both, plus what the fundamentals look like and what to check before you make any decision.
This article is for informational purposes only and isn’t financial advice. Always verify live pricing and do your own research (or talk to a licensed financial advisor) before investing.
What Is NVOS Stock?
NVOS is the ticker symbol for Novo Integrated Sciences, Inc., a healthcare company that, together with its subsidiaries, provides multidisciplinary primary care and related wellness products and services in Canada, operating through two segments: Healthcare Services and Product Sales.
The company offers a wide range of clinical services, including physiotherapy, chiropractic care, manual and manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury or neurological rehabilitation, kinesiology, vestibular therapy, and concussion management and baseline testing.
On the corporate side, Novo Integrated Sciences owns Canadian and U.S. subsidiaries built around multidisciplinary primary care and wellness products, delivered through medical technology, interconnectivity, advanced therapeutics, diagnostic solutions, personalized product offerings, and rehabilitative science. The company is led by CEO Robert Mattacchione, employs roughly 264 people, and trades on the OTC market rather than a major exchange like the Nasdaq or NYSE.
If you’re also curious how a related biotech arm fits into the picture, our earlier deep dive — NVOS Stock: Analyzing the Potential of Novosanis in the Biotech Sector — breaks down that side of the business in more detail.
NVOS Stock Price: Why It’s So Volatile
NVOS is a classic example of a low-priced, thinly traded OTC stock, and that comes with a specific set of characteristics worth understanding before anything else:
- Sub-penny to low-cent pricing. Recent quotes have shown the stock trading in the fractions-of-a-cent range, with a market cap in the roughly $1 million territory. At that size, even small dollar-value trades can move the price by double-digit percentages in a single session.
- A history of sharp swings. The stock has moved as much as 80% or more over a recent one-year period, and it has been reported falling around 97% from a prior high within a single year — the kind of range that’s common for micro-cap OTC names but unusual for larger, exchange-listed companies.
- A prior reverse split. Novo Integrated Sciences carried out a 1-for-10 reverse stock split, announced and effective in November 2023, which reduced the share count and proportionally raised the per-share price at the time. Reverse splits don’t change a company’s underlying value, but they do reset the price chart and can confuse anyone comparing historical prices without adjusting for it.
- Thin, inconsistent volume. Average daily volume figures vary a lot depending on the data source and time period, which is typical for stocks that trade over the counter rather than on a major exchange.
Because different data providers can show meaningfully different prices, market caps, and date stamps for the same OTC ticker, it’s worth cross-checking a live quote on more than one source — such as your brokerage app, Yahoo Finance, or stockanalysis.com — rather than relying on a single number, especially before placing a trade.
Key Financials at a Glance
Here’s a snapshot of the company’s most recently reported fundamentals:
| Metric | Figure |
|---|---|
| Ticker | NVOS |
| Exchange | OTC Markets |
| Sector / Industry | Healthcare / Medical Care Facilities |
| TTM Revenue | ~$13.3M |
| TTM Net Income | -$16.2M |
| TTM EPS (diluted) | -$0.89 |
| Net Profit Margin | -121.6% |
| Gross Profit Margin | 43.2% |
Looking at annual results, Novo Integrated Sciences reported fiscal-year 2024 revenue of $13.29 million, a 5.75% increase from the prior year’s $12.57 million, while net losses widened to $16.17 million, up 22.3% year over year. In short: revenue has been growing modestly, but the company is still operating at a significant net loss, which is an important factor to weigh alongside the share price itself.
What Moves NVOS Stock?
A handful of recurring factors tend to drive price action in a name like this:
- Corporate updates and partnerships. Press releases about new collaboration agreements, clinic expansions, or subsidiary developments can trigger short-term volume spikes.
- Quarterly and annual earnings. Revenue growth, margin changes, and updates on the net loss all get scrutinized closely given the company’s financial profile.
- Dilution and financing activity. Like many small-cap companies that are not yet profitable, financing moves (share issuances, warrants, debt conversions) can affect share count and, in turn, per-share value.
- Broader sentiment toward OTC healthcare micro-caps. Retail trading forums and social sentiment trackers often influence short-term moves in stocks like NVOS more than they would for a large-cap company. If you follow that side of the conversation, our related post on Nvos Stock Stocktwits rounds up how retail sentiment tools get used around this ticker.
How to Check Live NVOS Stock Data
Given how quickly OTC prices can move, always confirm current numbers directly rather than relying on any static article — including this one. A few reliable starting points:
- Your brokerage’s real-time quote page
- Yahoo Finance or stockanalysis.com for price history and news
- The company’s own investor relations page for official filings and press releases
For a broader breakdown of the company’s business segments and how they tie together, see our earlier post, Analyzing Novo Integrated Sciences (NVOS): A Comprehensive Overview, and for a longer-term look at price behavior, Navigating the Volatility: An Analysis of Novo Integrated Sciences Inc. Stock Price is worth a read.
If you want a general primer on how market capitalization is calculated and why it matters for a stock this size, Investopedia’s guide to market capitalization is a solid outside reference: <a href=”https://www.investopedia.com/terms/m/marketcapitalization.asp” rel=”nofollow” target=”_blank”>Market Capitalization Explained – Investopedia</a>.
NVOS Stock FAQ
Is NVOS stock on the Nasdaq or NYSE? No.
Novo Integrated Sciences trades on OTC Markets, not a major national exchange, which generally means lower liquidity and looser listing requirements than Nasdaq or NYSE-listed companies.
Has NVOS ever done a reverse stock split?
Yes. The company completed a 1-for-10 reverse split in November 2023, which adjusted the number of shares outstanding and the per-share price at that time.
Is Novo Integrated Sciences profitable?
Based on trailing twelve-month figures, the company reported a net loss with an EPS of roughly -$0.89 and a net profit margin of about -121.6%, so it has not been profitable on a trailing basis.
What sector does NVOS operate in?
Novo Integrated Sciences is classified in the healthcare sector, specifically medical care facilities, and it provides multidisciplinary primary care and wellness services through its Healthcare Services and Product Sales segments.
Final Thoughts
NVOS is a micro-cap, OTC-traded healthcare stock with a business model built around multidisciplinary clinical services in Canada, alongside a product-sales arm. The fundamentals show modest revenue growth alongside ongoing net losses, and the share price has a track record of significant volatility, including a past reverse split. None of that makes it inherently a “good” or “bad” stock — it just means it carries a different risk profile than a large, exchange-listed company, and it’s worth treating the numbers with extra care and always pulling a live quote before acting on anything you read here.
Disclaimer: This article is for general informational purposes only and does not constitute financial, investment, or trading advice. Stock prices, market caps, and financial metrics change constantly and may differ across data providers. Always confirm current data and consult a licensed financial advisor before making investment decisions.
